167 related articles for article (PubMed ID: 9703973)
1. A second p53-related protein, p73L, with high homology to p73.
Senoo M; Seki N; Ohira M; Sugano S; Watanabe M; Inuzuka S; Okamoto T; Tachibana M; Tanaka T; Shinkai Y; Kato H
Biochem Biophys Res Commun; 1998 Jul; 248(3):603-7. PubMed ID: 9703973
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51.
Senoo M; Tsuchiya I; Matsumura Y; Mori T; Saito Y; Kato H; Okamoto T; Habu S
Br J Cancer; 2001 May; 84(9):1235-41. PubMed ID: 11336476
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel retrovirus long terminal repeat (LTR) that is targeted by p51A (TAp63gamma) and selective dominant-negative activity of p73L (DeltaNp63alpha) toward p53-responsive promoter activities.
Senoo M; Matsumura Y; Habu S
Biochem Biophys Res Commun; 2001 Aug; 286(3):628-34. PubMed ID: 11511106
[TBL] [Abstract][Full Text] [Related]
4. The emerging p53 gene family.
Kaelin WG
J Natl Cancer Inst; 1999 Apr; 91(7):594-8. PubMed ID: 10203277
[TBL] [Abstract][Full Text] [Related]
5. A new human p53 homologue.
Trink B; Okami K; Wu L; Sriuranpong V; Jen J; Sidransky D
Nat Med; 1998 Jul; 4(7):747-8. PubMed ID: 9662346
[No Abstract] [Full Text] [Related]
6. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers.
Kaghad M; Bonnet H; Yang A; Creancier L; Biscan JC; Valent A; Minty A; Chalon P; Lelias JM; Dumont X; Ferrara P; McKeon F; Caput D
Cell; 1997 Aug; 90(4):809-19. PubMed ID: 9288759
[TBL] [Abstract][Full Text] [Related]
7. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
Yang A; Kaghad M; Wang Y; Gillett E; Fleming MD; Dötsch V; Andrews NC; Caput D; McKeon F
Mol Cell; 1998 Sep; 2(3):305-16. PubMed ID: 9774969
[TBL] [Abstract][Full Text] [Related]
8. p53 Family members p63 and p73 are SAM domain-containing proteins.
Thanos CD; Bowie JU
Protein Sci; 1999 Aug; 8(8):1708-10. PubMed ID: 10452616
[TBL] [Abstract][Full Text] [Related]
9. p63 and p73: roles in development and tumor formation.
Moll UM; Slade N
Mol Cancer Res; 2004 Jul; 2(7):371-86. PubMed ID: 15280445
[TBL] [Abstract][Full Text] [Related]
10. Structure, function and regulation of p63 and p73.
Levrero M; De Laurenzi V; Costanzo A; Gong J; Melino G; Wang JY
Cell Death Differ; 1999 Dec; 6(12):1146-53. PubMed ID: 10637429
[TBL] [Abstract][Full Text] [Related]
11. The p73 DNA binding domain displays enhanced stability relative to its homologue, the tumor suppressor p53, and exhibits cooperative DNA binding.
Patel S; Bui TT; Drake AF; Fraternali F; Nikolova PV
Biochemistry; 2008 Mar; 47(10):3235-44. PubMed ID: 18260640
[TBL] [Abstract][Full Text] [Related]
12. The p53 family: same response, different signals?
Chen X
Mol Med Today; 1999 Sep; 5(9):387-92. PubMed ID: 10462750
[TBL] [Abstract][Full Text] [Related]
13. AIS is an oncogene amplified in squamous cell carcinoma.
Hibi K; Trink B; Patturajan M; Westra WH; Caballero OL; Hill DE; Ratovitski EA; Jen J; Sidransky D
Proc Natl Acad Sci U S A; 2000 May; 97(10):5462-7. PubMed ID: 10805802
[TBL] [Abstract][Full Text] [Related]
14. p63 and p73: old members of a new family.
Marin MC; Kaelin WG
Biochim Biophys Acta; 2000 May; 1470(3):M93-M100. PubMed ID: 10799748
[No Abstract] [Full Text] [Related]
15. Expression profiles of p53, p63, and p73 in benign salivary gland tumors.
Weber A; Langhanki L; Schütz A; Gerstner A; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Nov; 441(5):428-36. PubMed ID: 12447671
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.
Zaika AI; Kovalev S; Marchenko ND; Moll UM
Cancer Res; 1999 Jul; 59(13):3257-63. PubMed ID: 10397274
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the p51 gene and correlation between p53, p73, and p51 expressions in prostatic carcinoma.
Takahashi H; Fukutome K; Watanabe M; Furusato M; Shiraishi T; Ito H; Suzuki H; Ikawa S; Hano H
Prostate; 2001 May; 47(2):85-90. PubMed ID: 11340630
[TBL] [Abstract][Full Text] [Related]
18. TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression.
Senoo M; Matsumura Y; Habu S
Oncogene; 2002 Apr; 21(16):2455-65. PubMed ID: 11971180
[TBL] [Abstract][Full Text] [Related]
19. Functional impairment of p73 and p51, the p53-related proteins, by the human T-cell leukemia virus type 1 Tax oncoprotein.
Kaida A; Ariumi Y; Ueda Y; Lin JY; Hijikata M; Ikawa S; Shimotohno K
Oncogene; 2000 Feb; 19(6):827-30. PubMed ID: 10698501
[TBL] [Abstract][Full Text] [Related]
20. Conformational stability and activity of p73 require a second helix in the tetramerization domain.
Coutandin D; Löhr F; Niesen FH; Ikeya T; Weber TA; Schäfer B; Zielonka EM; Bullock AN; Yang A; Güntert P; Knapp S; McKeon F; Ou HD; Dötsch V
Cell Death Differ; 2009 Dec; 16(12):1582-9. PubMed ID: 19763140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
